Two patients had therapy related eAML with extramedullary disease occurring 2 and 3 months after initial diagnosis of MDS and MPN respectively; along with evidence of monosomy 7, and PTPN11, and complex karyotyping in second patient. The gene discussed is PTPN11; the disease is myeloproliferative disorder.